Inflamm Bowel Dis . Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019-A Population-based Study

[tetano]

Inflamm Bowel Dis


. 2022 Mar 24;izac052.
doi: 10.1093/ibd/izac052. Online ahead of print.
Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019-A Population-based Study


Mohamed Attauabi ^{1 2 3} , Jens Frederik Dahlerup ⁴ , Anja Poulsen ⁵ , Malte Rosager Hansen ⁶ , Marianne Kajbæk Vester-Andersen ⁷ , August Pilegaard Prahm ⁵ , Natalia Pedersen ⁸ , Lone Larsen ⁹ , Tine Jess ^{9 10} , Anders Neumann ¹¹ , Kent V Haderslev ¹² , Akbar Molazahi ¹³ , Anders Berg Lødrup ¹⁴ , Henning Glerup ¹⁵ , Asser Mathiassen Oppfeldt ¹⁶ , Michael Dam Jensen ¹⁷ , Klaus Theede ^{2 3} , Marianne Kiszka-Kanowitz ^{2 3} , Jakob Benedict Seidelin ¹ , Johan Burisch ^{2 3}



Affiliations

• PMID: 35325137
• DOI: 10.1093/ibd/izac052

No abstract availableKeywords: COVID-19 outcomes; disease activity; inflammatory bowel diseases; population-based; sequelae.


Plain Language Summary

This brief report investigated the impact of clinical, biochemical, and endoscopic activity of IBD on the severity and long-term outcomes of COVID-19 in a prospective population-based cohort. The study did not identify any association between IBD activity and COVID-19 outcomes.